InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Hippel James, Chief Financial Officer. Director active across 1 companies, notably BIO-TECHNE Corp. Aggregated, 12 reports have been published. Total volume traded: €90k. The latest transaction was filed on 1 November 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations12 total
€954,5918,822 shares@ €108.20580.014% mcap26.1% of flow
Common Stock
SEC:0000914190-21-000403·
€954,5918,822 shares@ €108.20580.014% mcap13.0% of flow
Common Stock
SEC:0000914190-21-000403:0·
€44,950100 shares@ €449.50150.0007% mcap1.2% of flow
Common Stock
SEC:0000914190-21-000394·
€44,950100 shares@ €449.50150.0007% mcap0.6% of flow
Common Stock
SEC:0000914190-21-000394:0·
€897,48810,000 shares@ €89.74880.013% mcap24.5% of flow
Common Stock
SEC:0000914190-21-000359·
€897,48810,000 shares@ €89.74880.013% mcap12.2% of flow
Common Stock
SEC:0000914190-21-000359:0·
03,383 shares0
Common Stock
SEC:0000914190-21-000216·
03,383 shares0
Common Stock
SEC:0000914190-21-000216:0·
€898,34110,000 shares@ €89.83410.013% mcap24.5% of flow
Common Stock
SEC:0000914190-21-000195·
€898,34110,000 shares@ €89.83410.013% mcap12.3% of flow
Common Stock
SEC:0000914190-21-000195:0·
€869,0759,942 shares@ €87.41450.013% mcap11.9% of flow
Common Stock
SEC:0000914190-21-000181:0·
€869,0759,942 shares@ €87.41450.013% mcap23.7% of flow
Common Stock
SEC:0000914190-21-000181·
12 of 12 declarations
About Hippel James
James Hippel is Chief Financial Officer at BIO-TECHNE Corp. He is responsible for financial management and financial strategy for the company. His role is essential in ensuring financial health and compliance in operations.
